SAN DIEGO, Jan. 29, 2015 /PRNewswire/ -- Mirati Therapeutics, Inc. (NASDAQ: MRTX) today announced that the company will present a business overview and update at the Leerink Global Healthcare Conference on Thursday, February 12, 2015 at 8:55 a.m. Eastern Time in New York.
A live audio webcast of the presentation will be accessible on the Investors page of the Company’s website at www.mirati.com. Replays of the presentation will be available at the same location for 60 days following the conference.
About Mirati Therapeutics
Mirati Therapeutics is a targeted oncology company developing a pipeline of oncology therapeutics for precisely defined patient populations. Mirati’s approach combines the three most important factors in oncology drug development - drug candidates targeting genetic and epigenetic drivers of cancer, creative and agile clinical development that selects for patients whose tumors are dependent on those driver alterations, and a highly accomplished precision medicine leadership team. The Mirati team is using a blueprint proven by their prior work for developing potential breakthrough therapies with accelerated development paths. Mirati is currently advancing three drug candidates through clinical development for multiple oncology indications. More information is available at www.mirati.com.
Company Contact:
Mirati Therapeutics Inc.
Mark J. Gergen
Executive Vice President & COO
858-332-3410
Investor Relations and Media Relations:
Jason Spark
Canale Communications
619-849-6005
jason@canalecomm.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/mirati-therapeutics-to-present-at-the-leerink-global-healthcare-conference-300025151.html
SOURCE Mirati Therapeutics, Inc.
Help employers find you! Check out all the jobs and post your resume.
